Drug-Like Small Molecules That Inhibit Expression of the Oncogenic MicroRNA-21.

Area of Science:

• Biochemistry
• Molecular Biology
• Drug Discovery

Background:

• MicroRNA-21 (miR-21) is implicated in oncogenesis and inflammation.
• Dysregulation of miR-21 contributes to various pathologies.
• Targeting miRNA biogenesis offers a therapeutic strategy.

Purpose of the Study:

• To discover small molecules that specifically inhibit miR-21 precursor processing.
• To investigate the mechanism of action for these novel inhibitors.
• To evaluate the therapeutic potential of these molecules in cancer models.

Main Methods:

• High-throughput screening for small molecule binders to miR-21 precursor.
• Biochemical assays to determine binding affinity and mechanism of inhibition.
• Cell-based assays to assess effects on miR-21 levels and cellular proliferation.
• Structure-activity relationship studies.

Main Results:

• Identified drug-like small molecules with mid-nanomolar affinity for miR-21 precursor.
• Molecules induce structural changes at the Dicer cleavage site, inhibiting miRNA processing.
• Potent compounds reduce cancer cell proliferation and miR-21 levels without off-target effects.
• Specificity confirmed by nucleotide substitutions and testing on other miRNA precursors.

Conclusions:

• Novel small molecules effectively suppress miR-21 maturation.
• These compounds represent a promising therapeutic avenue for miR-21-driven diseases.
• Ligand-efficient molecules demonstrate specific biochemical and cellular activity.